2 sources checked · 2 source groups included · 6m ago
Still Watching
Major dementia breakthrough as twice-yearly jab halves the rate of cognitive decline making it most powerful treatment yet - here's how YOU could access it
The Independent and Daily Mail describe the same event in different terms.
1 Left0 Center1 Right
Still watching.Optics is waiting for a cleaner match before calling the split.
STILL WATCHING
As of November 19, 2026 at 11:04 AM, this is how Optics News reads the wording differences in this story.
What happenedPatients given a jab named diranersen experienced 54 per cent less decline in memory and thinking skills over almost two years, in a major trial.
The headline splitThe left frames it as "Alzheimer’s jab ‘halves rate of cognitive decline’ in major trial: ‘Very encouraging’". The right frames it as "Major dementia breakthrough as twice-yearly jab halves the rate of cognitive decline maki...".
Match confidenceDeveloping. The source map is still developing. Keep watching for more sources to join.
Same-event confidenceDeveloping
Not enough sources yet to confirm this is the same specific event.
Framing confidenceHidden
Wording-gap score hidden — source map is too narrow to read confidently.
WHAT EACH SIDE EMPHASIZED
Left / center-leftAlzheimer’s jab ‘halves rate of cognitive decline’ in major trial: ‘Very encouraging’
The Independent · Center-left · News report
CenterNo matching source in this bucket yet.
Optics keeps watching for pickup.
Right / center-rightMajor dementia breakthrough as twice-yearly jab halves the rate of cognitive decline making it most powerful treatment yet - here...
Major dementia breakthrough as twice-yearly jab halves the rate of cognitive decline making it most powerful treatment yet - here's how YOU could access it
Patients given a jab named diranersen experienced 54 per cent less decline in memory and thinking skills over almost two years, in a major trial.